US Stocks
/
Xilio Therapeutics, Inc. Share Price
Xilio Therapeutics, Inc. Share Price

Xilio Therapeutics, Inc. Share Price

NASDAQ: XLO | Micro Cap
$8.01
+$0.56 (7.52%) Last updated on 29 Oct, 2026 | 01:28 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Xilio Therapeutics, Inc. Stock Performance

Open
$8.01
Prev. Close
$7.45
Circuit Range
N/A
Day Range
$8.01 - $8.01
Year Range
$0.47 - $9.75
Volume
149
Average Traded
$8.01

Xilio Therapeutics, Inc. Share Price Today

As of 29 October 2026, Xilio Therapeutics, Inc.'s share price is $8.01. The stock opened at $8.01, compared to its previous close of $7.45. During today's trading session, Xilio Therapeutics, Inc.'s share price traded between $8.01 and $8.01, with an average price of $8.01. Over the past 52 weeks, the stock has recorded a high of $9.75 and a low of $0.47. In terms of performance, Xilio Therapeutics, Inc.'s share price has risen by 0.63% over the last six months and is up 907.55% on a year-on-year basis.

Xilio Therapeutics, Inc. Share Price Chart

$8.01$8.01
L
Show Current Price
H

Xilio Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$66.96M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-3.32
Revenue (TTM)
$43.77B
Return On Equity (TTM)
-30.21%
Profit Margin
-80.05%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
60.90%

Xilio Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$19.07$13.69$12.65$18.69
Net Profit-$16.29$10.36-$9.53-$6.37
Net Profit Margin-85.42%75.68%-75.34%-34.08%
Income ChangeN/A163.60%-191.99%33.16%

Xilio Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$6.34$43.77
Net Profit-$88.22-$76.40-$58.24-$35.04
Net Profit MarginN/AN/A-918.61%-80.05%
Income ChangeN/A13.40%23.77%39.84%

About Xilio Therapeutics, Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology and capabilities, the company develops I-O therapies designed to selectively activate within the tumor microenvironment to achieve durable efficacy without the severe side effects associated with systemically active I-O agents. Its integrated biology and protein engineering approach enables the design and development of potent masked biologics that are activated by tumor-specific proteases.

Xilio Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$9.00
$8.01
-10.90%
Sep 2026
$9.05
$8.99
-1.69%
Aug 2026
$9.18
$9.14
-0.27%
Jul 2026
$9.08
$9.17
-3.22%
Jun 2026
$8.43
$9.47
+11.80%
May 2026
$8.43
$8.47
+6.47%
Apr 2026
$8.58
$7.96
-6.02%
Mar 2026
$0.52
$8.47
+1,495.10%
Feb 2026
$0.58
$0.53
-10.30%
Jan 2026
$0.64
$0.59
-7.93%
Dec 2025
$0.75
$0.64
-14.49%
Nov 2025
$0.82
$0.75
-5.41%

XLO Share Price FAQs

What is Xilio Therapeutics, Inc. share price today?

chevron-up
Xilio Therapeutics, Inc. share price today is $8.01 as on October 29, 2026 at 1:28 am IST.

What is the 52 week high and 52 week low of Xilio Therapeutics, Inc. stock?

chevron-up
The 52 week high of Xilio Therapeutics, Inc. stock is $9.75, while the 52 week low is $0.47 as of 29 Oct '26.

What is XLO's market capitalisation today?

chevron-up
XLO market capitalisation is $66.96M as of October 29, 2026, at 11:08 am IST.

What is XLO's net income for the last quarter?

chevron-up
XLO's net income for the last quarter is -6.37B USD.

What is the 5 year returns of XLO?

chevron-up
The 5 year returns of XLO is -52.29% as on 29 Oct '26.

What is the high & low stock price of XLO today?

chevron-up
XLO stock price hit a high of $8.01 and low of $8.01 as of 29 Oct '26.

Can I buy XLO shares in India?

chevron-up
Yes. You can buy XLO in India by opening an international trading account.